Financial Snapshot

Revenue
$5.509M
TTM
Gross Margin
Net Earnings
-$13.27M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
49.93%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
-$7.625M
Q2 2024
Cash
Q2 2024
P/E
-0.6577
Sep 13, 2024 EST
Free Cash Flow
-$10.65M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Revenue $4.913M $224.0K $0.00 $300.0K $7.000M $3.671M $2.689M $4.656M $4.838M $7.600M $12.20M $14.50M $10.00M $10.63M $14.73M $6.850M $6.050M $7.930M $6.010M $6.820M $14.09M $9.170M $5.650M $6.250M $1.510M $0.00 $0.00
YoY Change 2093.3% -100.0% -95.71% 90.68% 36.52% -42.25% -3.76% -36.34% -37.7% -15.86% 45.0% -5.93% -27.83% 115.04% 13.22% -23.71% 31.95% -11.88% -51.6% 53.65% 62.3% -9.6% 313.91%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Revenue $4.913M $224.0K $0.00 $300.0K $7.000M $3.671M $2.689M $4.656M $4.838M $7.600M $12.20M $14.50M $10.00M $10.63M $14.73M $6.850M $6.050M $7.930M $6.010M $6.820M $14.09M $9.170M $5.650M $6.250M $1.510M $0.00 $0.00
Cost Of Revenue $1.148M $1.318M $2.715M $3.186M $2.940M $3.420M $4.000M $3.840M $3.910M $3.390M $1.850M $420.0K $1.630M $3.150M $3.380M $4.240M $4.560M $4.150M $2.390M $490.0K
Gross Profit $2.523M $146.0K $1.941M $1.652M $4.660M $8.780M $10.50M $6.160M $6.720M $11.34M $5.000M $5.630M $6.300M $2.850M $3.430M $9.840M $4.600M $1.500M $3.860M $1.030M
Gross Profit Margin 68.73% 5.43% 41.69% 34.15% 61.32% 71.97% 72.41% 61.6% 63.22% 76.99% 72.99% 93.06% 79.45% 47.42% 50.29% 69.84% 50.16% 26.55% 61.76% 68.21%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Selling, General & Admin $8.544M $10.24M $6.853M $6.410M $5.290M $7.597M $8.041M $12.17M $12.43M $22.36M $25.06M $25.16M $28.29M $23.61M $17.00M $16.33M $16.86M $14.60M $11.76M $8.960M $10.36M $9.230M $9.190M $10.88M $4.330M $880.0K $310.0K
YoY Change -16.55% 49.39% 6.91% 21.17% -30.37% -5.52% -33.95% -2.04% -44.42% -10.77% -0.4% -11.06% 19.82% 38.88% 4.1% -3.14% 15.48% 24.15% 31.25% -13.51% 12.24% 0.44% -15.53% 151.27% 392.05% 183.87%
% of Gross Profit 301.11% 5507.53% 627.2% 752.24% 479.83% 285.42% 239.62% 459.25% 351.34% 149.91% 326.6% 299.47% 231.75% 412.63% 261.22% 105.28% 200.65% 612.67% 281.87% 420.39%
Research & Development $9.690M $9.698M $5.323M $2.700M $0.00 $0.00 $5.073M $16.20M $19.00M $15.11M $17.07M $13.63M $10.90M $9.690M $12.23M $17.37M $20.02M $21.98M $15.45M $10.38M $8.690M $5.610M $5.490M $2.580M $1.170M $1.180M $300.0K
YoY Change -0.08% 82.19% 97.15% -100.0% -68.68% -14.75% 25.74% -11.48% 25.24% 25.05% 12.49% -20.77% -29.59% -13.24% -8.92% 42.27% 48.84% 19.45% 54.9% 2.19% 112.79% 120.51% -0.85% 293.33%
% of Gross Profit 0.0% 3474.66% 834.47% 1150.12% 324.25% 194.42% 129.81% 176.95% 144.2% 107.85% 347.4% 355.6% 348.89% 542.11% 302.62% 88.31% 121.96% 366.0% 66.84% 113.59%
Depreciation & Amortization $628.0K $619.0K $400.0K $366.0K $896.0K $2.004M $2.151M $1.182M $1.093M $780.0K $1.630M $930.0K $860.0K $930.0K $1.680M $1.530M $1.620M $2.120M $1.720M $1.750M $1.660M $1.470M $1.180M $440.0K $210.0K $110.0K $10.00K
YoY Change 1.45% 54.75% 9.29% -59.15% -55.29% -6.83% 81.98% 8.14% 40.13% -52.15% 75.27% 8.14% -7.53% -44.64% 9.8% -5.56% -23.58% 23.26% -1.71% 5.42% 12.93% 24.58% 168.18% 109.52% 90.91% 1000.0%
% of Gross Profit 79.43% 1473.29% 60.9% 66.16% 16.74% 18.56% 8.86% 13.96% 13.84% 14.81% 30.6% 28.77% 33.65% 60.35% 51.02% 16.87% 31.96% 78.67% 11.4% 20.39%
Operating Expenses $18.23M $19.94M $5.323M $9.887M $10.66M $16.98M $14.80M $28.37M $23.76M $37.47M $42.12M $38.79M $39.19M $33.30M $29.24M $33.70M $36.88M $36.58M $27.20M $19.35M $19.06M $14.83M $14.68M $13.47M $5.500M $2.060M $610.0K
YoY Change -8.54% 274.53% -46.16% -7.21% -37.25% 14.72% -47.83% 19.41% -36.59% -11.04% 8.58% -1.02% 17.69% 13.89% -13.23% -8.62% 0.82% 34.49% 40.57% 1.52% 28.52% 1.02% 8.98% 144.91% 166.99% 237.7%
Operating Profit -$13.32M -$19.71M -$12.49M -$9.584M -$3.657M -$12.70M -$11.08M -$19.71M -$15.29M -$32.81M -$33.34M -$28.29M -$33.03M -$26.58M -$17.90M -$28.70M -$31.25M -$30.28M -$24.35M -$15.92M -$9.220M -$10.23M -$13.18M -$9.610M -$4.470M
YoY Change -32.42% 57.8% 30.34% 162.07% -71.2% 14.62% -43.78% 28.92% -53.41% -1.59% 17.85% -14.35% 24.27% 48.49% -37.63% -8.16% 3.2% 24.35% 52.95% 72.67% -9.87% -22.38% 37.15% 114.99%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Interest Expense $400.0K $700.0K $900.0K $1.100M $1.855M $1.922M $2.049M $2.592M $4.300M -$4.000M $4.170M -$3.510M $840.0K -$780.0K -$5.060M -$1.250M $770.0K $4.940M -$3.490M $80.00K $290.0K $580.0K $2.250M $1.140M -$100.0K -$30.00K $10.00K
YoY Change -42.86% -22.22% -18.18% -40.7% -3.49% -6.2% -20.95% -39.72% -207.5% -195.92% -218.8% -517.86% -207.69% -84.58% 304.8% -262.34% -84.41% -241.55% -4462.5% -72.41% -50.0% -74.22% 97.37% -1240.0% 233.33% -400.0%
% of Operating Profit
Other Income/Expense, Net $5.000K -$563.0K -$907.0K $0.00 $374.0K -$116.0K -$2.003M -$2.340M $172.0K -$610.0K -$440.0K -$310.0K -$60.00K $20.00K -$220.0K -$40.00K -$50.00K -$30.00K -$60.00K $20.00K $90.00K
YoY Change -100.89% -37.93% -100.0% -422.41% -94.21% -14.4% -1460.47% -128.2% 38.64% 41.94% 416.67% -400.0% -109.09% 450.0% -20.0% 66.67% -50.0% -400.0% -77.78%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Pretax Income -$13.32M -$20.28M -$13.40M -$8.241M -$3.439M -$8.346M -$12.23M -$20.39M -$18.74M -$37.37M -$26.18M -$32.28M -$32.45M -$27.49M -$23.22M -$30.04M -$28.67M -$25.45M -$26.54M -$2.090M -$9.280M -$13.19M -$11.04M -$8.470M -$4.570M -$2.090M -$600.0K
YoY Change -34.32% 51.32% 62.59% 139.63% -58.79% -31.76% -40.01% 8.79% -49.85% 42.74% -18.9% -0.52% 18.04% 18.39% -22.7% 4.78% 12.65% -4.11% 1169.86% -77.48% -29.64% 19.47% 30.34% 85.34% 118.66% 248.33%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$13.30M -$20.30M -$13.40M -$8.241M -$10.89M -$12.63M -$22.69M -$22.05M -$18.74M -$37.37M -$26.18M -$32.28M -$32.45M -$27.49M -$23.22M -$30.04M -$28.67M -$25.45M -$26.54M -$2.090M -$9.280M -$13.19M -$11.04M -$8.470M -$4.570M -$2.090M -$600.0K
YoY Change -34.48% 51.49% 62.6% -24.3% -13.83% -44.31% 2.9% 17.62% -49.84% 42.74% -18.9% -0.52% 18.04% 18.39% -22.7% 4.78% 12.65% -4.11% 1169.86% -77.48% -29.64% 19.47% 30.34% 85.34% 118.66% 248.33%
Net Earnings / Revenue -270.71% -9062.5% -2747.0% -155.53% -344.16% -843.66% -473.5% -387.43% -491.71% -214.59% -222.62% -324.5% -258.61% -157.64% -438.54% -473.88% -320.93% -441.6% -30.65% -65.86% -143.84% -195.4% -135.52% -302.65%
Basic Earnings Per Share -$4.24 -$0.77 -$1.11
Diluted Earnings Per Share -$4.24 -$0.77 -$1.108M -$1.860M -$7.891M -$74.29M -$378.2M -$735.0M -$937.0M -$3.737B -$2.618B -$3.228B -$3.245B -$2.749B -$4.845B -$8.379B -$9.394B -$11.49B -$13.54B -$1.125B -$4.783B -$6.763B -$5.546B -$7.740B -$9.913B -$4.823B -$1.385B

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Cash & Short-Term Investments $8.554M $18.12M $18.40M $8.350M $17.55M $5.260M $9.550M $12.56M $14.34M $14.62M $15.51M $25.72M $36.92M $52.67M $12.85M $12.61M $11.47M $12.88M $15.85M $13.42M $14.27M $24.98M $33.95M $44.48M $2.580M $140.0K $420.0K
YoY Change -52.79% -1.52% 120.36% -52.42% 233.65% -44.92% -23.96% -12.41% -1.92% -5.74% -39.7% -30.34% -29.9% 309.88% 1.9% 9.94% -10.95% -18.74% 18.11% -5.96% -42.87% -26.42% -23.67% 1624.03% 1742.86% -66.67%
Cash & Equivalents $8.554M $18.12M $18.40M $8.350M $17.55M $5.260M $9.550M $12.56M $14.34M $14.62M $15.51M $25.72M $36.92M $52.67M $12.85M $12.61M $11.47M $8.900M $8.010M $2.840M $2.820M $5.110M $2.700M $7.480M $2.470M $40.00K $320.0K
Short-Term Investments $0.00 $3.980M $7.840M $10.58M $11.45M $19.88M $31.25M $37.01M $110.0K $110.0K $100.0K
Other Short-Term Assets $1.280M $3.697M $1.324M $830.0K $850.0K $4.100M $1.990M $1.220M $1.300M $880.0K $1.110M $1.050M $600.0K $710.0K $790.0K $850.0K $700.0K $650.0K $510.0K $980.0K $530.0K $840.0K $850.0K $880.0K $30.00K $30.00K $0.00
YoY Change -65.38% 179.23% 59.52% -2.35% -79.27% 106.03% 63.11% -6.15% 47.73% -20.72% 5.71% 75.0% -15.49% -10.13% -7.06% 21.43% 7.69% 27.45% -47.96% 84.91% -36.9% -1.18% -3.41% 2833.33% 0.0%
Inventory $0.00 $110.0K $110.0K $3.180M $3.730M $4.300M $4.830M $3.690M $3.180M $3.320M $3.380M $2.590M $2.140M $0.00 $160.0K $260.0K $380.0K $830.0K $1.150M $1.690M $2.280M $1.140M $40.00K $0.00
Prepaid Expenses
Receivables $0.00 $1.170M $180.0K $150.0K $1.240M $1.050M $1.240M $4.150M $3.930M $2.260M $2.070M $1.630M $1.310M $10.00K $230.0K $820.0K $860.0K $1.290M $1.240M $460.0K $690.0K $490.0K $0.00 $0.00
Other Receivables $0.00 $140.0K $0.00 $0.00 $0.00 $260.0K $120.0K $110.0K $110.0K $230.0K $130.0K $230.0K $310.0K $70.00K $60.00K $110.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $9.834M $21.82M $19.72M $9.180M $19.83M $9.650M $14.86M $18.75M $21.24M $21.69M $24.58M $33.98M $43.34M $58.95M $18.10M $17.23M $12.24M $13.98M $17.54M $15.65M $16.92M $28.21M $36.95M $48.34M $4.240M $210.0K $420.0K
YoY Change -54.93% 10.61% 114.86% -53.71% 105.49% -35.06% -20.75% -11.72% -2.07% -11.76% -27.66% -21.6% -26.48% 225.69% 5.05% 40.77% -12.45% -20.3% 12.08% -7.51% -40.02% -23.65% -23.56% 1040.09% 1919.05% -50.0%
Property, Plant & Equipment $1.108M $1.572M $1.818M $2.460M $2.960M $2.300M $3.050M $1.160M $1.630M $1.580M $1.050M $2.170M $1.710M $1.680M $1.310M $2.550M $3.430M $4.700M $4.260M $3.080M $3.820M $3.630M $5.170M $3.690M $1.320M $800.0K $90.00K
YoY Change -29.52% -13.53% -26.1% -16.89% 28.7% -24.59% 162.93% -28.83% 3.16% 50.48% -51.61% 26.9% 1.79% 28.24% -48.63% -25.66% -27.02% 10.33% 38.31% -19.37% 5.23% -29.79% 40.11% 179.55% 65.0% 788.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $90.00K $250.0K $460.0K $280.0K $320.0K $370.0K $80.00K $0.00 $0.00 $900.0K
YoY Change -100.0% -64.0% -45.65% 64.29% -12.5% -13.51% 362.5% -100.0%
Other Assets $32.00K $12.00K $16.00K $20.00K $70.00K $11.67M $2.570M $2.340M $1.870M $2.110M $3.160M $3.090M $2.120M $920.0K $500.0K $730.0K $470.0K $430.0K $460.0K $240.0K $330.0K $560.0K $130.0K $240.0K $20.00K $10.00K $0.00
YoY Change 166.67% -25.0% -20.0% -71.43% -99.4% 354.09% 9.83% 25.13% -11.37% -33.23% 2.27% 45.75% 130.43% 84.0% -31.51% 55.32% 9.3% -6.52% 91.67% -27.27% -41.07% 330.77% -45.83% 1100.0% 100.0%
Total Long-Term Assets $1.554M $2.050M $2.257M $2.930M $3.400M $14.34M $16.76M $15.86M $16.46M $17.03M $17.48M $9.270M $8.190M $7.400M $6.650M $8.380M $9.270M $10.89M $10.63M $9.820M $11.17M $11.11M $6.190M $3.930M $1.340M $810.0K $100.0K
YoY Change -24.2% -9.17% -22.97% -13.82% -76.29% -14.44% 5.67% -3.65% -3.35% -2.57% 88.57% 13.19% 10.68% 11.28% -20.64% -9.6% -14.88% 2.45% 8.25% -12.09% 0.54% 79.48% 57.51% 193.28% 65.43% 710.0%
Total Assets $11.39M $23.87M $21.98M $12.11M $23.23M $23.99M $31.62M $34.61M $37.70M $38.72M $42.06M $43.25M $51.53M $66.35M $24.75M $25.61M $21.51M $24.87M $28.17M $25.47M $28.09M $39.32M $43.14M $52.27M $5.580M $1.020M $520.0K
YoY Change
Accounts Payable $4.758M $8.364M $2.611M $790.0K $330.0K $2.780M $4.790M $5.870M $1.010M $950.0K $970.0K $1.580M $270.0K $600.0K $1.150M $460.0K $480.0K $730.0K $930.0K $480.0K $520.0K $600.0K $290.0K $780.0K $330.0K $260.0K $10.00K
YoY Change -43.11% 220.34% 230.51% 139.39% -88.13% -41.96% -18.4% 481.19% 6.32% -2.06% -38.61% 485.19% -55.0% -47.83% 150.0% -4.17% -34.25% -21.51% 93.75% -7.69% -13.33% 106.9% -62.82% 136.36% 26.92% 2500.0%
Accrued Expenses $1.993M $1.880M $1.529M $1.140M $2.970M $0.00 $5.460M $4.410M $4.970M $5.800M $5.030M $6.150M $4.170M $4.300M $6.540M $4.490M $4.380M $1.660M $2.000M $1.900M $860.0K $580.0K $310.0K $230.0K $20.00K
YoY Change 6.01% 22.96% 34.12% -61.62% 23.81% -11.27% -14.31% 15.31% -18.21% 47.48% -3.02% -34.25% 45.66% 2.51% 163.86% -17.0% 5.26% 120.93% 48.28% 87.1% 34.78% 1050.0%
Deferred Revenue
YoY Change
Short-Term Debt $3.976M $1.608M $1.608M $6.340M $0.00 $14.20M $13.62M $6.630M $0.00 $7.360M $3.190M $9.780M $2.490M $6.450M $2.710M $2.050M $720.0K $1.000M $950.0K $940.0K $720.0K $410.0K $560.0K $0.00 $0.00 $170.0K $0.00
YoY Change 147.26% 0.0% -74.64% -100.0% 4.26% 105.43% -100.0% 130.72% -67.38% 292.77% -61.4% 138.01% 32.2% 184.72% -28.0% 5.26% 1.06% 30.56% 75.61% -26.79% -100.0%
Long-Term Debt Due $0.00 $0.00 $10.00K $11.18M $0.00 $1.750M $3.010M $5.090M $0.00 $120.0K $120.0K $90.00K $50.00K $0.00
YoY Change -100.0% -99.91% -100.0% -41.86% -40.86% -100.0% 0.0% 33.33% 80.0%
Total Short-Term Liabilities $10.73M $11.85M $5.870M $8.540M $14.49M $17.56M $18.41M $12.50M $8.440M $15.92M $14.91M $17.61M $7.820M $13.22M $8.180M $7.140M $8.070M $6.590M $7.080M $3.190M $4.480M $2.910M $1.830M $1.480M $730.0K $700.0K $30.00K
YoY Change -9.49% 101.91% -31.26% -41.06% -17.48% -4.62% 47.28% 48.1% -46.98% 6.77% -15.33% 125.19% -40.85% 61.61% 14.57% -11.52% 22.46% -6.92% 121.94% -28.79% 53.95% 59.02% 23.65% 102.74% 4.29% 2233.33%
Long-Term Debt $0.00 $3.786M $5.005M $0.00 $10.00K $0.00 $0.00 $11.01M $16.68M $18.04M $23.10M $12.90M $21.96M $13.26M $2.790M $5.040M $240.0K $1.160M $1.560M $1.130M $1.160M $770.0K $1.930M $260.0K $300.0K $210.0K $0.00
YoY Change -100.0% -24.36% -100.0% -100.0% -33.99% -7.54% -21.9% 79.07% -41.26% 65.61% 375.27% -44.64% 2000.0% -79.31% -25.64% 38.05% -2.59% 50.65% -60.1% 642.31% -13.33% 42.86%
Other Long-Term Liabilities $2.009M $1.784M $270.0K $540.0K $7.580M $1.210M $200.0K $110.0K $370.0K $10.46M $920.0K $6.280M $11.81M $17.00M $17.43M $21.15M $22.60M $27.94M $25.76M $8.320M $7.540M $9.640M $900.0K $1.200M
YoY Change 12.61% 560.74% -50.0% -92.88% 526.45% 505.0% 81.82% -70.27% -96.46% 1036.96% -85.35% -46.82% -30.53% -2.47% -17.59% -6.42% -19.11% 8.46% 209.62% 10.34% -21.78% 971.11% -25.0%
Total Long-Term Liabilities $2.009M $5.570M $5.275M $540.0K $7.590M $1.210M $200.0K $11.12M $17.05M $28.50M $24.02M $19.18M $33.77M $30.26M $20.22M $26.19M $22.84M $29.10M $27.32M $9.450M $8.700M $10.41M $2.830M $1.460M $300.0K $210.0K $0.00
YoY Change -63.93% 5.59% 876.85% -92.89% 527.27% 505.0% -98.2% -34.78% -40.18% 18.65% 25.23% -43.2% 11.6% 49.65% -22.79% 14.67% -21.51% 6.52% 189.1% 8.62% -16.43% 267.84% 93.84% 386.67% 42.86%
Total Liabilities $12.74M $17.42M $11.15M $9.070M $22.07M $18.77M $18.62M $23.62M $25.49M $44.42M $38.93M $36.80M $41.59M $43.47M $28.41M $33.33M $30.91M $35.68M $34.40M $12.64M $13.18M $13.32M $4.660M $2.930M $1.030M $910.0K $30.00K
YoY Change -26.9% 56.32% 22.88% -58.9% 17.58% 0.81% -21.17% -7.34% -42.62% 14.1% 5.79% -11.52% -4.32% 53.01% -14.76% 7.83% -13.37% 3.72% 172.15% -4.1% -1.05% 185.84% 59.04% 184.47% 13.19% 2933.33%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Basic Shares Outstanding 3.141M 26.26M 12.09M
Diluted Shares Outstanding 3.141M 26.26M 12.09M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $8.7266 Million

About Plus Therapeutics Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The company is headquartered in Austin, Texas and currently employs 20 full-time employees. The company went IPO on 2000-08-09. The firm is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The firm combines image-guided local beta radiation and targeted drug delivery approaches. The firm is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). Its radiotherapeutic candidate, rhenium (186Re) obisbemeda, is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC). The Company’s Rhenium (186Re) obisbemeda, a novel injectable radiotherapy designed to deliver targeted, high dose radiation directly into GBM tumors. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers.

Industry: Surgical & Medical Instruments & Apparatus Peers: Bone Biologics Corp Allarity Therapeutics Inc American CryoStem Corp Protagenic Therapeutics Inc CervoMed Inc Salarius Pharmaceuticals Inc Qualigen Therapeutics Inc ProtoKinetix Inc